Cigna is poised to grow its international and commercial health coverage, and the fundamental parts of the health insurer's business are becoming stronger, according to BMO Capital.
Analyst Dave Shove raised his 12-month price target on the stock to $65 from $60 after the Bloomfield, Conn., company met with analysts Friday at its annual investor day presentation.
Cigna has a broader product portfolio than some of its competitors. It operates health care, group disability and life segments in the United States. The insurer also has an international segment that sells individual insurance in several countries and operates an expatriate business that covers people living outside their home countries.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
